Improve Your Treatment Success Rates
Seed captures male factors that are
missed by the standard semen analysis helping you provide better care to
Discover if your patient has epigenetic abnormalities in genes associated with infertility. These abnormalities may decrease the chance of conceiving naturally or through artificial insemination.
Good embryo quality is an important factor for a successful in-vitro fertilization procedure. Seed can help you understand if embryo development is going to be a problem and maximize your chances for a successful IVF cycle.
Seed is the first male fertility test to predict infertility and sperm’s role in embryo development by analyzing 480,000 regions on your DNA for epigenetic abnormalities, making it easier to guide treatment decisions with actionable information a semen analysis can’t provide.
From the report:
Your epigenetic profile suggests significantly elevated risk for male factor infertility.
The presence of epigenetic abnormalities may decrease your chance of conceiving naturally or through artificial insemination. Because of this, you may want to consider more advanced treatments such as in-vitro fertilization (IVF).
For every patient’s gene that contains epigenetic abnormalities, the Seed report links to any available research, allowing you to investigate how treatment may be affected.
Seed results can help you counsel patients with visual representations of the severity of their fertility problems, as well as guide them to the treatment that is most likely to work for their case.
It takes just minutes for us to set you up so you can order your first test.
You or your staff can fill out a requisition order right on our website.
We handle all the logistics with your patient, including payment.
We’ll let you know when the report is ready and you can view it securely on our website